All Stories

  1. Availability and Costs of Allergic Rhinitis Treatments Across the World: A Survey of ARIA Experts
  2. Systemic sclerosis-associated pulmonary arterial hypertension and pulmonary fibrosis: exploring biomarker discriminators with advanced omics in a Caucasian cohort
  3. Multicenter international cohort study of HA20 reveals novel genetic architecture and phenotypic evolution
  4. Global disparities in adrenaline access: A World Allergy Organization call for equity in anaphylaxis care
  5. Methodology for the Development of the Allergic Rhinitis and Its Impact on Asthma ( ARIA )‐EAACI 2024–2025 Guidelines: From Evidence‐to‐Decision Frameworks to Digitalised Shared Decision‐Making Algorithms
  6. Key Predictors of Adherence to a Mobile Health App for Managing Chronic Spontaneous Urticaria
  7. Characterization of ambient air quality and its relationship with respiratory morbidity in typical cities of Northwest China (NWC)
  8. Case Report: Not all recurrent “idiopathic” anaphylaxis is idiopathic
  9. A World Allergy Organization (WAO) manifesto for the worldwide approval of biologic therapies for food allergy
  10. Unmet needs in hereditary angioedema: an international survey of physicians
  11. Defining Clinical Remission in Severe Asthma: Expert Opinion From the Gulf Region Using the Modified Delphi Method
  12. In-house assays for detecting anti-SARS-CoV-2 antibodies in serum and urine: Correlation with COVID-19 severity from a cohort study in Qatar
  13. Secondary Non-Response to Biologic Treatment in Patients with Severe Asthma
  14. Contact Urticaria and Related Conditions: Clinical Review
  15. WAO - ARIA consensus on chronic cough: Executive summary
  16. Challenges in diagnosing polyethylene glycol and polysorbate 80 allergies: implications for allergic reactions in COVID-19 mRNA vaccination program: experience from Qatar
  17. Intravenous immunoglobulin therapy: usage patterns and response to treatment in Qatar over ten years
  18. Perceptions of the impact of individual allergic rhinitis symptoms: A survey of ARIA clinical experts
  19. Concepts for the Development of Person-Centered, Digitally Enabled, Artificial Intelligence–Assisted ARIA Care Pathways (ARIA 2024)
  20. Usage prevalence of angioedema patient–reported outcome measures: Results from the UCARE and ACARE PROMUSE study
  21. Patient-Reported Outcome Measures in Atopic Dermatitis and Chronic Urticaria Are Underused in Clinical Practice
  22. Etiology of bronchiectasis in Qatar: A retrospective study
  23. Urticaria exacerbations and adverse reactions in patients with chronic urticaria receiving COVID-19 vaccination: Results of the UCARE COVAC-CU study
  24. The first case report of complement component 7 deficiency in Qatar and a 10-year follow-up
  25. Expert opinion on management of moderate-to-severe atopic dermatitis in Qatar
  26. Epidemiology of combined immunodeficiencies affecting cellular and humoral immunity– a multicentric retrospective cohort study from the Arabian Peninsula
  27. Severe exercise-induced anaphylaxis in a hot and humid area successfully treated with omalizumab: a case report
  28. Fc Epsilon RI–Neuroimmune Interplay in Pruritus Triggered by Particulate Matter in Atopic Dermatitis Patients
  29. Auto-immunoproteomics analysis of COVID-19 ICU patients revealed increased levels of autoantibodies related to the male reproductive system
  30. Uncovering a neurological protein signature for severe COVID-19
  31. A review of patch-test data over the period of eight years in the allergy and immunology department in Qatar
  32. Aeroallergens sensitization pattern in atopic patients in Qatar: A retrospective study
  33. Case report: Challenges in the diagnosis of Eosinophilic esophagitis
  34. Circulating microRNA signatures in patients with chronic Urticaria
  35. Subcutaneous immunoglobulin therapy for adult patients with primary immunodeficiency disease: Qatar experience
  36. The Second Qatar Allergy and Immunology Conference: An Editorial
  37. The rate of exacerbations in patients with asthma in Qatar: A retrospective study during 2019-2021
  38. Predictors of Early Death Among Untransplanted Patients with Combined immunodeficiencies affecting cellular and humoral immunity
  39. The Middle East and North Africa Diagnosis and Management Guidelines for Inborn Errors of Immunity
  40. Predictors of early death risk among untransplanted patients with combined immunodeficiencies affecting cellular and humoral immunity: A multicenter report
  41. Anaphylaxis after prick‐to‐prick skin test to seafood allergy: A rare adverse event
  42. BCG Vaccine–associated Complications in a Large Cohort of Children With Combined Immunodeficiencies Affecting Cellular and Humoral Immunity
  43. Aerobiological monitoring in a desert type ecosystem: Two sampling stations of two cities (2017–2020) in Qatar
  44. Digital tools in allergy and respiratory care
  45. Chronic urticaria and COVID-19 vaccination: Qatar data (preliminary report of COVAC-CU-international)
  46. Contributions of nurse specialists in the allergy and immunology service and patient care
  47. Do we need aerobiological air monitoring in desert climates? The Qatar experience
  48. Selective COX-2 inhibitor continues to be a safe alternative in patients with nonselective NSAIDs hypersensitivity
  49. Severity and outcome of COVID-19 disease in patients with allergic rhinitis during the pandemic in Qatar – A preliminary report
  50. Sulphamethoxazole-trimethoprim induced fixed drug eruption in a patient with Chronic Granulomatous Disease
  51. Aspirin challenge and desensitization in patients with suspected AERD in Qatar
  52. Circulatory EVs as a predictor of chronic urticarial activity
  53. First allergy conference in Qatar: Let's explore allergy with a new lens
  54. Real-world experience of the clinical effectiveness of omalizumab use in Qatar – a study protocol
  55. SCIG administration: A promising and patient convenient alternative for those receiving long-term IVIG
  56. Correlation between skin test results and historical manifestations in patients with suspected lidocaine hypersensitivity
  57. First volumetric records of airborne Cladosporium and Alternaria spores in the atmosphere of Al Khor (northern Qatar): a preliminary survey
  58. Untargeted Metabolomics Profiling Reveals Perturbations in Arginine-NO Metabolism in Middle Eastern Patients with Coronary Heart Disease
  59. Allergic manifestations of inborn errors of immunity and their impact on the diagnosis: A worldwide study
  60. Untargeted Metabolomics Identifies a Novel Panel of Markers for Autologous Blood Transfusion
  61. WAO-ARIA consensus on chronic cough – Part III: Management strategies in primary and cough-specialty care. Updates in COVID-19
  62. The correlation between middle schoolchildren allergic symptoms and airborne particle season
  63. Viral exanthem following influenza vaccine
  64. A Retrospective Study of Non-Communicable Diseases amongst Blue-Collar Migrant Workers in Qatar
  65. Prognostic tools and candidate drugs based on plasma proteomics of patients with severe COVID-19 complications
  66. Auto-Immunoproteomics Analysis of COVID-19 ICU Patients Revealed Increased Levels of Autoantibodies Related to Male Reproductive System
  67. Emerging COVID-19 variants and their impact on SARS-CoV-2 diagnosis, therapeutics and vaccines
  68. Association of endometriosis with interstitial cystitis in chronic pelvic pain syndrome: Short narrative on prevalence, diagnostic limitations, and clinical implications
  69. WAO-ARIA consensus on chronic cough – Part 1: Role of TRP channels in neurogenic inflammation of cough neuronal pathways
  70. WAO-ARIA consensus on chronic cough - Part II: Phenotypes and mechanisms of abnormal cough presentation — Updates in COVID-19
  71. Abstract 13039: Putative Protective Effects Of Caffeine And Its Metabolites On Coronary Heart Disease In The Middle East
  72. Abstract 13041: Differences In Systemic Fatty Acids Between Coronary Heart Disease Patients And Controls From The Middle East Favors Inflammation
  73. Primary immunodeficiency and the microbiome
  74. In vitro Interleukin-7 treatment partially rescues MAIT cell dysfunction caused by SARS-CoV-2 infection
  75. Consensus Middle East and North Africa Registry on Inborn Errors of Immunity
  76. METABOLOMICS REVEALS PERTURBATIONS IN ARGININE-NO METABOLISM, PURINE BIOSYNTHESIS AND CELLULAR ENERGY CHARGE IN PATIENTS WITH CORONARY HEART DISEASE
  77. REPRODUCTIBILITY OF A METABOLITE RISK SCORE TO PREDICT CORONARY HEART DISEASE IN A MIDDLE EASTERN POPULATION
  78. Age, Disease Severity and Ethnicity Influence Humoral Responses in a Multi-Ethnic COVID-19 Cohort
  79. Robust prognostic signatures derived from proteomic panel profiling of plasma from patients with severe COVID-19 complications
  80. Evaluation of Antibody Response in Symptomatic and Asymptomatic COVID-19 Patients and Diagnostic Assessment of New IgM/IgG ELISA Kits
  81. Performance evaluation of five ELISA kits for detecting anti-SARS-COV-2 IgG antibodies
  82. A founder RAB27A variant causes Griscelli syndrome type 2 with phenotypic heterogeneity in Qatari families
  83. The association between airborne pollen monitoring and sensitization in the hot desert climate
  84. Definition, aims, and implementation of GA2LEN/HAEi Angioedema Centers of Reference and Excellence
  85. Immunogenetics of Celiac Disease: A Focus on Arab Countries
  86. The Association Between Airborne Pollen Monitoring and Sensitization in the Hot Desert Climate
  87. Etiology and outcome of hemoptysis in Qatar, a high-resource country with a large expatriate population: A retrospective study
  88. A Novel STAT3 Mutation in a Qatari Patient With Hyper-IgE Syndrome
  89. Anaphylaxis triggers in a large tertiary care hospital in Qatar: a retrospective study
  90. Delayed clavulanic acid–induced anaphylaxis in a patient undergoing bariatric surgery
  91. Complex Regional Pain Syndrome Type I Following Tetanus Toxoid Injection
  92. Two cases of food-dependent exercise-induced anaphylaxis with different culprit foods
  93. Renal allograft tuberculosis with infected lymphocele transmitted from the donor
  94. Primary Cutaneous Vasculitis Masquerading as Drug Induced following Aspirin Desensitization
  95. Two Cases of Recurrent Episodes of Angio Edema Without Urticaria or Pruritus
  96. Prevalence of Pharmacogenetic Risk Alleles in a Consanguineous Middle Eastern Population.